Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

ADVM


Fundamental

Company: Adverum Biotechnologies Inc
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -6.39
Insider Own: 33.78%
Shs Outstand: 20.89M
Perf Week: -13.07%
Market Cap: 51.39M
Forward P/E: -
EPS next Y: -3.69
Insider Trans: 14.32%
Shs Float: 13.83M
Perf Month: 19.42%
Income: -133.56M
PEG: -
EPS next Q: -2.25
Inst Own: 58.54%
Short Float: 14.06%
Perf Quarter: -46.64%
Sales: 1.00M
P/S: 51.39
EPS this Y: 7.31%
Inst Trans: 0.63%
Short Ratio: 5.85
Perf Half Y: -58.23%
Book/sh: 1.26
P/B: 1.95
EPS next Y Percentage: 39.93%
ROA: -65.88%
Short Interest: 1.94M
Perf Year: -66.35%
Cash/sh: 3.98
P/C: 0.62
EPS next 5Y: 12.12%
ROE: -127.99%
52W Range From: 1.78
52W Range To: 10.14
Perf YTD: -47.32%
Dividend Est.: -
P/FCF: -
EPS past 5Y: 8.03%
ROIC: -118.86%
52W High: -75.74%
Beta: 0.72
Dividend TTM: -
Quick Ratio: 3.57
Sales past 5Y: 31.95%
Gross Margin: -233.90%
52W Low: 38.20%
ATR (14): 0.25
Dividend Ex-Date: -
Current Ratio: 3.57
EPS Y/Y TTM: 37.54%
Oper. Margin: -15364.20%
RSI (14): 45.26
Volatility W: 3.28%
Volatility M: 6.38%
Employees: 155
Debt/Eq: 3.53
Sales Y/Y TTM: -72.22%
Profit Margin: -13356.00%
Recom: 1.40
Target Price: 22.33
Option/Short: Yes / Yes
LT Debt/Eq: 3.25
EPS Q/Q: -49.29%
Payout: -
Rel Volume: 0.55
Prev Close: 2.59
Sales Surprise: -
EPS Surprise: -15.98%
Sales Q/Q: -
Earnings: May 14 AMC
Avg Volume: 332.17K
Price: 2.46
SMA20: 1.33%
SMA50: -13.19%
SMA200: -51.72%
Trades:
Volume: 182,091
Change: -5.02%

Technical:


Latest News:

Analysts' Top Healthcare Picks: Adverum Biotechnologies (ADVM), Gilead Sciences (GILD) somewhat bullish
ADVM GILD CVRX

Summary: Analysts are bullish on Adverum Biotechnologies (ADVM), Gilead Sciences (GILD), and CVRx (CVRX) in the Healthcare sector.

Full article
2025-02-13T15:11:42Z